Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 19397469)

1.

Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure.

Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML.

Tissue Eng Part A. 2009 Nov;15(11):3377-88. doi: 10.1089/ten.TEA.2008.0681.

2.

Transplantation of human stem cell-derived hepatocytes in an animal model of acute liver failure.

Ramanathan R, Pettinato G, Beeston JT, Lee DD, Wen X, Mangino MJ, Fisher RA.

Surgery. 2015 Aug;158(2):349-59. doi: 10.1016/j.surg.2015.04.014. Epub 2015 May 29.

PMID:
26032830
3.

The Reg3α (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver Failure.

Moniaux N, Darnaud M, Garbin K, Dos Santos A, Guettier C, Samuel D, Amouyal G, Amouyal P, Bréchot C, Faivre J.

PLoS One. 2015 May 4;10(5):e0125584. doi: 10.1371/journal.pone.0125584. eCollection 2015.

4.

Adipose-derived stem cell-based treatment for acute liver failure.

Chen G, Jin Y, Shi X, Qiu Y, Zhang Y, Cheng M, Wang X, Chen C, Wu Y, Jiang F, Li L, Zhou H, Fu Q, Liu X.

Stem Cell Res Ther. 2015 Mar 21;6:40. doi: 10.1186/s13287-015-0040-2.

5.

The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.

Liu WH, Song FQ, Ren LN, Guo WQ, Wang T, Feng YX, Tang LJ, Li K.

J Cell Mol Med. 2015 Mar;19(3):511-20. doi: 10.1111/jcmm.12482. Epub 2014 Dec 23.

6.

Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors.

Rodrigues RM, Sachinidis A, De Boe V, Rogiers V, Vanhaecke T, De Kock J.

Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.

PMID:
25458485
7.

[Diagnosis and therapies for acute liver failure: scientific developments].

Ott M, Cantz T, Schneider A, Manns MP.

Internist (Berl). 2014 Nov;55(11):1288-95. doi: 10.1007/s00108-014-3507-9. Review. German.

PMID:
25315763
8.

Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.

Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M.

Stem Cells. 2014 Nov;32(11):2818-23. doi: 10.1002/stem.1818.

PMID:
25154380
9.

High throughput micro-well generation of hepatocyte micro-aggregates for tissue engineering.

Gevaert E, Dollé L, Billiet T, Dubruel P, van Grunsven L, van Apeldoorn A, Cornelissen R.

PLoS One. 2014 Aug 18;9(8):e105171. doi: 10.1371/journal.pone.0105171. eCollection 2014. Erratum in: PLoS One. 2014;9(1):e114315.

10.

Effects of coencapsulation of hepatocytes with adipose-derived stem cells in the treatment of rats with acute-on-chronic liver failure.

Zhang Y, Chen XM, Sun DL.

Int J Artif Organs. 2014 Feb;37(2):133-41. doi: 10.5301/ijao.5000284. Epub 2014 Feb 7.

PMID:
24619896
11.

Current status of human hepatocyte transplantation and its potential for Wilson's disease.

Filippi C, Dhawan A.

Ann N Y Acad Sci. 2014 May;1315:50-5. doi: 10.1111/nyas.12386. Epub 2014 Mar 7. Review.

PMID:
24605914
12.

Two-tier regenerative response in liver failure in humans.

Rastogi A, Maiwall R, Bihari C, Trehanpati N, Pamecha V, Sarin SK.

Virchows Arch. 2014 May;464(5):565-73. doi: 10.1007/s00428-014-1547-0. Epub 2014 Mar 4.

PMID:
24590583
13.

Mesenchymal stem cells support hepatocyte function in engineered liver grafts.

Kadota Y, Yagi H, Inomata K, Matsubara K, Hibi T, Abe Y, Kitago M, Shinoda M, Obara H, Itano O, Kitagawa Y.

Organogenesis. 2014 Apr-Jun;10(2):268-77. doi: 10.4161/org.27879. Epub 2014 Jan 31.

14.

Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.

Nagaishi K, Ataka K, Echizen E, Arimura Y, Fujimiya M.

Hepatology. 2014 May;59(5):1816-29. doi: 10.1002/hep.26975. Epub 2014 Apr 1.

PMID:
24375439
15.

Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes.

Fitzpatrick E, Wu Y, Dhadda P, Hughes RD, Mitry RR, Qin H, Lehec SC, Heaton ND, Dhawan A.

Cell Transplant. 2015;24(1):73-83. doi: 10.3727/096368913X674080. Epub 2013 Oct 18.

PMID:
24143888
16.

Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.

Seo KW, Sohn SY, Bhang DH, Nam MJ, Lee HW, Youn HY.

Cell Biol Int. 2014 Jan;38(1):106-16. doi: 10.1002/cbin.10186. Epub 2013 Oct 17.

PMID:
24115681
17.

Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury.

Salomone F, Barbagallo I, Puzzo L, Piazza C, Li Volti G.

Stem Cell Res. 2013 Nov;11(3):1037-44. doi: 10.1016/j.scr.2013.07.003. Epub 2013 Jul 25.

18.

Administration of IL-1Ra chitosan nanoparticles enhances the therapeutic efficacy of mesenchymal stem cell transplantation in acute liver failure.

Xiao JQ, Shi XL, Ma HC, Tan JJ, Lin-zhang, Xu Q, Ding YT.

Arch Med Res. 2013 Jul;44(5):370-9. doi: 10.1016/j.arcmed.2013.06.004. Epub 2013 Jul 31.

PMID:
23916885
19.

Construction of liver tissue in vivo with preparative partial hepatic irradiation and growth stimulus: investigations of less invasive techniques and progenitor cells.

Miyazaki K, Yamanouchi K, Sakai Y, Yamaguchi I, Takatsuki M, Kuroki T, Guha C, Eguchi S.

J Surg Res. 2013 Dec;185(2):889-95. doi: 10.1016/j.jss.2013.06.016. Epub 2013 Jun 29.

PMID:
23845872
20.

Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism.

Jung J, Choi JH, Lee Y, Park JW, Oh IH, Hwang SG, Kim KS, Kim GJ.

Stem Cells. 2013 Aug;31(8):1584-96. doi: 10.1002/stem.1396.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk